Serotonin potentiates transforming growth factor-beta3 induced biomechanical remodeling in avian embryonic atrioventricular valves

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Buskohl, Philip R ^a   Sun, Michelle L ^a   Thompson, Robert P ^b   Butcher, Jonathan T ^a  

^a Cornell University   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN TRANSPORTER; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CELL PROLIFERATION; CHICK; CONTROLLED STUDY; EMBRYO; EX VIVO STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART ATRIOVENTRICULAR VALVE; HEART VENTRICLE SEPTUM DEFECT; MECHANICAL STRESS; MESENCHYME; NONHUMAN; RIGIDITY; SIGNAL TRANSDUCTION;

ANIMALS; BIOMECHANICS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHICK EMBRYO; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART SEPTAL DEFECTS; HEART VALVES; HUMANS; MESODERM; MYOCARDIAL CONTRACTION; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SEROTONIN; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA3; VENTRICULAR REMODELING;

AVES; SPONDIAS PURPUREA;

EID: 84864705146     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042527     Document Type: Article

References (74)

1. Butcher JT, Sedmera D, Guldberg RE, Markwald RR, ((2007)) Quantitative volumetric analysis of cardiac morphogenesis assessed through micro-computed tomography. Dev Dyn 236 (3):802-809.
2. Hu N, Clark EB, ((1989)) Hemodynamics of the stage 12 to stage 29 chick embryo. Circ Res 65 (6):1665-1670.
3. Keller BB, Hu N, Serrino PJ, Clark EB, ((1991)) Ventricular pressure-area loop characteristics in the stage 16 to 24 chick embryo. Circ Res 68 (1):226-231.
4. Yalcin HC, Shekhar A, McQuinn TC, Butcher JT, ((2011)) Hemodynamic patterning of the avian atrioventricular valve. Dev Dyn 240 (1):23-35.
5. Kruithof BP, Krawitz SA, Gaussin V, ((2007)) Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling. Dev Biol 302 (1):208-217.
6. Hinton RB Jr, Lincoln J, Deutsch GH, Osinska H, Manning PB, et al. ((2006)) Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res 98 (11):1431-1438.
7. Person AD, Klewer SE, Runyan RB, ((2005)) Cell biology of cardiac cushion development. Int Rev Cytol 243:287-335.
8. Combs MD, Yutzey KE, ((2009)) Heart valve development: Regulatory networks in development and disease. Circ Res 105 (5):408-421.
9. Butcher JT, Markwald RR, ((2007)) Valvulogenesis: The moving target. Philos Trans R Soc Lond B Biol Sci 362 (1484):1489-1503.
10. Eisenberg LM, Markwald RR, ((1995)) Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 77 (1):1-6.
11. Attisano L, Wrana JL, Lopez-Casillas F, Massague J, ((1994)) TGF-beta receptors and actions. Biochim Biophys Acta 1222 (1):71-80.
12. Massague J, Chen YG, ((2000)) Controlling TGF-beta signaling. Genes Dev 14 (6):627-644.
13. Shi Y, Massague J, ((2003)) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (6):685-700.
14. Potts JD, Runyan RB, ((1989)) Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor beta. Dev Biol 134 (2):392-401.
15. Boyer AS, Ayerinskas II, Vincent EB, McKinney LA, Weeks DL, et al. ((1999)) TGFbeta2 and TGFbeta3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev Biol 208 (2):530-545.
16. Camenisch TD, Molin DG, Person A, Runyan RB, Gittenberger-de Groot AC, et al. ((2002)) Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev Biol 248 (1):170-181.
17. Bartram U, Molin DG, Wisse LJ, Mohamad A, Sanford LP, et al. ((2001)) Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-beta(2)-knockout mice. Circulation 103 (22):2745-2752.
18. Azhar M, Runyan RB, Gard C, Sanford LP, Miller ML, et al. ((2009)) Ligand-specific function of transforming growth factor beta in epithelial-mesenchymal transition in heart development. Dev Dyn 238 (2):431-442.
19. Potts JD, Vincent EB, Runyan RB, Weeks DL, ((1992)) Sense and antisense TGF beta 3 mRNA levels correlate with cardiac valve induction. Dev Dyn 193 (4):340-345.
20. Norris RA, Moreno-Rodriguez RA, Sugi Y, Hoffman S, Amos J, et al. ((2008)) Periostin regulates atrioventricular valve maturation. Dev Biol 316 (2):200-213.
21. Butcher JT, McQuinn TC, Sedmera D, Turner D, Markwald RR, ((2007)) Transitions in early embryonic atrioventricular valvular function correspond with changes in cushion biomechanics that are predictable by tissue composition. Circ Res 100 (10):1503-1511.
22. Buskohl PR, Gould RA, Butcher JT, ((2012)) Quantification of embryonic atrioventricular valve biomechanics during morphogenesis. J Biomech 45 (5):895-902.
23. Chiu YN, Norris RA, Mahler G, Recknagel A, Butcher JT, ((2010)) Transforming growth factor beta, bone morphogenetic protein, and vascular endothelial growth factor mediate phenotype maturation and tissue remodeling by embryonic valve progenitor cells: Relevance for heart valve tissue engineering. Tissue Eng Part A 16 (11):3375-85.
24. Norris RA, Potts JD, Yost MJ, Junor L, Brooks T, et al. ((2009)) Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev Dyn 238 (5):1052-1063.
25. Jian B, Xu J, Connolly J, Savani RC, Narula N, et al. ((2002)) Serotonin mechanisms in heart valve disease I: Serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells. Am J Pathol 161 (6):2111-2121.
26. Disatian S, Orton EC, ((2009)) Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease. J Heart Valve Dis 18 (1): 44-51.
27. El-Hamamsy I, Balachandran K, Yacoub MH, Stevens LM, Sarathchandra P, et al. ((2009)) Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. J Am Coll Cardiol 53 (16):1448-1455.
28. Warnock JN, Gamez CA, Metzler SA, Chen J, Elder SH, et al. ((2010)) Vasoactive agents alter the biomechanical properties of aortic heart valve leaflets in a time-dependent manner. J Heart Valve Dis 19 (1):86-95; discussion 96.
29. Roth BL, Willins DL, Kristiansen K, Kroeze WK, ((1998)) 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): Where structure meets function. Pharmacol Ther 79 (3):231-257.
30. Balachandran K, Hussain S, Yap CH, Padala M, Chester AH, et al. ((2011)) Elevated cyclic stretch and serotonin result in altered aortic valve remodeling via a mechanosensitive 5-HT(2A) receptor-dependent pathway. Cardiovasc Pathol.
31. Hafizi S, Taylor PM, Chester AH, Allen SP, Yacoub MH, ((2000)) Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents. J Heart Valve Dis 9 (3):454-458.
32. Oyama MA, Levy RJ, ((2010)) Insights into serotonin signaling mechanisms associated with canine degenerative mitral valve disease. J Vet Intern Med 24 (1):27-36.
33. Lauder JM, ((1988)) Neurotransmitters as morphogens. Prog Brain Res 73:365-387.
34. Levin M, Buznikov GA, Lauder JM, ((2006)) Of minds and embryos: Left-right asymmetry and the serotonergic controls of pre-neural morphogenesis. Dev Neurosci 28 (3):171-185.
35. Moiseiwitsch JR, Lauder JM, ((1995)) Serotonin regulates mouse cranial neural crest migration. Proc Natl Acad Sci U S A 92 (16):7182-7186.
36. Fukumoto T, Blakely R, Levin M, ((2005)) Serotonin transporter function is an early step in left-right patterning in chick and frog embryos. Dev Neurosci 27 (6):349-363.
37. Sadler TW, ((2011)) Selective serotonin reuptake inhibitors (SSRIs) and heart defects: Potential mechanisms for the observed associations. Reprod Toxicol 32 (4):484-9.
38. Lauder JM, Wilkie MB, Wu C, Singh S, ((2000)) Expression of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors in the mouse embryo. Int J Dev Neurosci 18 (7):653-662.
39. Choi DS, Ward SJ, Messaddeq N, Launay JM, Maroteaux L, ((1997)) 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells. Development 124 (9):1745-1755.
40. Millan FA, Denhez F, Kondaiah P, Akhurst RJ, ((1991)) Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development 111 (1):131-143.
41. Yavarone MS, Shuey DL, Tamir H, Sadler TW, Lauder JM, ((1993)) Serotonin and cardiac morphogenesis in the mouse embryo. Teratology 47 (6):573-584.
42. Nakajima Y, Miyazono K, Kato M, Takase M, Yamagishi T, et al. ((1997)) Extracellular fibrillar structure of latent TGF beta binding protein-1: Role in TGF beta-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse embryonic heart. J Cell Biol 136 (1):193-204.
43. Pavone LM, Spina A, Rea S, Santoro D, Mastellone V, et al. ((2009)) Serotonin transporter gene deficiency is associated with sudden death of newborn mice through activation of TGF-beta1 signalling. J Mol Cell Cardiol 47 (5):691-697.
44. Watts SW, Priestley JR, Thompson JM, ((2009)) Serotonylation of vascular proteins important to contraction. PLoS One 4 (5):e5682.
45. Jaffre F, Bonnin P, Callebert J, Debbabi H, Setola V, et al. ((2009)) Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy. Circ Res 104 (1):113-123.
46. Aoki T, Ohashi T, Matsumoto T, Sato M, ((1997)) The pipette aspiration applied to the local stiffness measurement of soft tissues. Ann Biomed Eng 25 (3):581-587.
47. Zhao R, Sider KL, Simmons CA, ((2011)) Measurement of layer-specific mechanical properties in multilayered biomaterials by micropipette aspiration. Acta Biomater 7 (3):1220-1227.
48. Fung YC, ((1991)) What are the residual stresses doing in our blood vessels? Ann Biomed Eng 19 (3):237-249.
49. Bookout AL, Mangelsdorf DJ, ((2003)) Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl Recept Signal 1:e012.
50. Elangbam CS, Job LE, Zadrozny LM, Barton JC, Yoon LW, et al. ((2008)) 5-hydroxytryptamine (5HT)-induced valvulopathy: Compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in sprague-dawley rats. Exp Toxicol Pathol 60 (4-5):253-262.
51. Hauso O, Gustafsson BI, Loennechen JP, Stunes AK, Nordrum I, et al. ((2007)) Long-term serotonin effects in the rat are prevented by terguride. Regul Pept 143 (1-3):39-46.
52. Miller CE, Thompson RP, Bigelow MR, Gittinger G, Trusk TC, et al. ((2005)) Confocal imaging of the embryonic heart: How deep? Microsc Microanal 11 (3):216-223.
53. Kern CB, Norris RA, Thompson RP, Argraves WS, Fairey SE, et al. ((2007)) Versican proteolysis mediates myocardial regression during outflow tract development. Dev Dyn 236 (3):671-683.
54. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, et al. ((2002)) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62 (1):65-74.
55. Guilluy C, Rolli-Derkinderen M, Tharaux PL, Melino G, Pacaud P, et al. ((2007)) Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells. J Biol Chem 282 (5):2918-2928.
56. Liu Y, Wei L, Laskin DL, Fanburg BL, ((2010)) Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 44 (4):548-55.
57. Todorovic V, Finnegan E, Freyer L, Zilberberg L, Ota M, et al. ((2011)) Long form of latent TGF-beta binding protein 1 (Ltbp1L) regulates cardiac valve development. Dev Dyn 240 (1):176-187.
58. Merryman WD, Lukoff HD, Long RA, Engelmayr GC Jr, Hopkins RA, et al. ((2007)) Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. Cardiovasc Pathol 16 (5):268-276.
59. Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA, ((2004)) Valvular myofibroblast activation by transforming growth factor-beta: Implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 95 (3):253-260.
60. Xu J, Jian B, Chu R, Lu Z, Li Q, et al. ((2002)) Serotonin mechanisms in heart valve disease II: The 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells. Am J Pathol 161 (6):2209-2218.
61. Yabanoglu S, Akkiki M, Seguelas MH, Mialet-Perez J, Parini A, et al. ((2009)) Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors. J Mol Cell Cardiol 46 (4):518-525.
62. Gustafsson BI, Tommeras K, Nordrum I, Loennechen JP, Brunsvik A, et al. ((2005)) Long-term serotonin administration induces heart valve disease in rats. Circulation 111 (12):1517-1522.
63. Monassier L, Laplante MA, Ayadi T, Doly S, Maroteaux L, ((2010)) Contribution of gene-modified mice and rats to our understanding of the cardiovascular pharmacology of serotonin. Pharmacol Ther 128 (3):559-567.
64. Hoffman JI, Kaplan S, ((2002)) The incidence of congenital heart disease. J Am Coll Cardiol 39 (12):1890-1900.
65. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A, ((2008)) Prevalence of congenital heart defects in metropolitan atlanta, 1998-2005. J Pediatr 153 (6):807-813.
66. Merlob P, Birk E, Sirota L, Linder N, Berant M, et al. ((2009)) Are selective serotonin reuptake inhibitors cardiac teratogens? echocardiographic screening of newborns with persistent heart murmur. Birth Defects Res A Clin Mol Teratol 85 (10):837-841.
67. Qi X, Yang G, Yang L, Lan Y, Weng T, et al. ((2007)) Essential role of Smad4 in maintaining cardiomyocyte proliferation during murine embryonic heart development. Dev Biol 311 (1):136-146.
68. Chen Q, Chen H, Zheng D, Kuang C, Fang H, et al. ((2009)) Smad7 is required for the development and function of the heart. J Biol Chem 284 (1):292-300.
69. Hove JR, Koster RW, Forouhar AS, Acevedo-Bolton G, Fraser SE, et al. ((2003)) Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature 421 (6919):172-177.
70. Azhar M, Brown K, Gard C, Chen H, Rajan S, et al. ((2011)) Transforming growth factor Beta2 is required for valve remodeling during heart development. Dev Dyn 240 (9):2127-2141.
71. Mekontso-Dessap A, Brouri F, Pascal O, Lechat P, Hanoun N, et al. ((2006)) Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation 113 (1):81-89.
72. Yalcin HC, Shekhar A, Nishimura N, Rane AA, Schaffer CB, et al. ((2010)) Two-photon microscopy guided femtosecond-laser photoablation of avian cardiogenesis: Noninvasive creation of localized heart defects. Am J Physiol Heart Circ Physiol.
73. Sedmera D, Pexieder T, Rychterova V, Hu N, Clark EB, ((1999)) Remodeling of chick embryonic ventricular myoarchitecture under experimentally changed loading conditions. Anat Rec 254 (2):238-252.
74. Nebigil CG, Hickel P, Messaddeq N, Vonesch JL, Douchet MP, et al. ((2001)) Ablation of serotonin 5-HT(2B) receptors in mice leads to abnormal cardiac structure and function. Circulation 103 (24):2973-2979.